Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

A novel CX3CR1 antagonist eluting stent reduces stenosis by targeting inflammation.

A novel CX3CR1 antagonist eluting stent reduces stenosis by targeting inflammation. Biomaterials. 2015 Nov; 69:22-9.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.